Home > News > Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
February 11th, 2004
Nanobiotech Pioneers Predict Nanomedicine Impact within Five Years
With nanobiotech research growing at an astounding rate - and funds starting to follow - what are the most promising near-term prospects for nanomedicine? Predicting which applications will have the resources - and luck - to succeed is a dicey proposition, experts acknowledge. But NanoBiotech News posed the questions to the field's preeminent pioneers and found that real-world applications of nanomedicine will happen within five years. Ground-breaking nanotechnology researcher Ralph C. Merkle, Ph.D., and the father of nanomedicine Robert A. Freitas, Jr., JD, are among the industry heavyweights who weighed in with NanoBiotech News on the state of the science and where it's headed.
Production of Anticancer Drug from Nanofibers in Iran November 28th, 2014
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014
ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014